Reduction of plasma CGRP levels in migraine patients treated with erenumab or galcanezumab. Garcia-Estevez DA, Juanatey-Garcia A, Rodriguez-Garrido J, Sabbagh-Casado N, et al. Rev Neurol 2024;78:293-294.

Read + Share

Amedeo Smart

Independent Medical Education

Garcia-Estevez DA, Juanatey-Garcia A, Rodriguez-Garrido J, Sabbagh-Casado N, et al. Reduction of plasma CGRP levels in migraine patients treated with erenumab or galcanezumab. Rev Neurol 2024;78:293-294.
PMID: 38743023